While state and local governments are filing a profusion of suits against drug companies to recoup costs of the opioid crisis, the trend has been slow to take hold in New Jersey. But opioid litigation is seen as having strong prospects if it can zero in on malfeasance by drug manufacturers and distributors, some observers said.
A half-dozen states have filed suits against drugmakers over the opioid crisis, and New Jersey is part of a coalition of 41 states that is investigating the role of pharmaceutical manufacturers and distributors in the growth in addiction to opioids. But even as Gov. Chris Christie has made fighting drug addiction a top priority for the remainder of his term, Attorney General Christopher Porrino indicated on Monday that the state is taking a cautious approach toward deciding whether to address the problem through litigation.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
